Accounting reportsPreviously
|
Name | ZAMBON FARMA, OOO |
---|
INN | 7704654651 |
---|
KPP | 770401001 |
---|
OGRN | 1077757775182 |
---|
OKPO | 81505472 |
---|
Address | 119002, G.moskva, per. Glazovskiy, d. D.7 |
---|
Phone | Contact details |
|
OKVED code | Type | Name of activity type |
---|
46.46 | Core activity | Wholesale of pharmaceutical goods | 21.10 | Additional activity | Manufacture of manmade fibres | 21.20 | Additional activity | Manufacturers of drugs and pharmaceuticals and medical products | All types of activities | 46.18.1 | Additional activity | Agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents | 46.46.1 | Additional activity | Wholesale of furniture, carpets and lighting equipment | 46.46.2 | Additional activity | Wholesale of medical and orthopedic goods, dental and laboratory supplies | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | 52.10.9 | Additional activity | Khranenie i skladirovanie prochikh gruzov | 70.22 | Additional activity | Advice on business and management | 71.20 | Additional activity | Technical testing, analysis and certification | 72.19 | Additional activity | Research and experimental development on natural sciences and engineering Other | 73.11 | Additional activity | Activities of advertising agencies | 73.20.1 | Additional activity | Market and opinion research |
Registration date | 10.07.2007 |
---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 46 po g. Moskve |
---|
|
ZAMBON FARMA, OOO (Moscow; INN 7704654651) was registered on 10 Jul 2007. The company's authorized capital as of July 1, 2012 was 456003000 rub. Type of ownership of ZAMBON FARMA, OOO - Limited liability companies. Form of ownership of ZAMBON FARMA, OOO - Property of foreign legal entities. Principal activities of ZAMBON FARMA, OOO: wholesale of pharmaceutical goods (46.46), manufacture of manmade fibres (21.10), manufacturers of drugs and pharmaceuticals and medical products (21.20). |
Economic indicators2023
Net profit (RAS) of ZAMBON FARMA, OOO grew over 2023 34.39 times to 200.03 million RUB from 5.82 million RUB over 2022, the company informed. Revenue remained in the accounting period at the same level and made up 5.61 billion RUB compared to 5.61 billion RUB 5.61 billion RUB; cost of goods sold decreased by 6.78% to 4.65 billion RUB from 4.99 billion RUB; sales profit went up by 1.54% to 253.03 million RUB from 249.20 million RUB. 2022
Net profit (RAS) of ZAMBON FARMA, OOO dropped in 2022 21.40 times to 5.82 million RUB from 124.46 million RUB over the same period in 2021, the company informed. Revenue increased in the accounting period by 12.58% to 5.61 billion RUB from 4.98 billion RUB over 2021; cost of goods sold grew by 14.69% to 4.99 billion RUB from 4.35 billion RUB; sales profit fell by 11.04% to 249.20 million RUB from 280.12 million RUB. 2021
Net profit (RAS) of ZAMBON FARMA, OOO dropped in 2021 by 20.56% to 124.46 million RUB from 156.68 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 26.37% to 4.98 billion RUB from 3.94 billion RUB over 2020; cost of goods sold grew by 27.22% to 4.35 billion RUB from 3.42 billion RUB; sales profit went up by 27.45% to 280.12 million RUB from 219.78 million RUB. 2020
Net profit (RAS) of ZAMBON FARMA, OOO grew over 2020 by 24.34% to 156.68 million RUB from 126.01 million RUB over 2019, the company informed. Revenue increased in the accounting period by 4.97% to 3.94 billion RUB from 3.75 billion RUB over 2019; cost of goods sold grew by 4.92% to 3.42 billion RUB from 3.26 billion RUB; sales profit fell by 0.54% to 219.78 million RUB from 220.98 million RUB. 2019
Net profit (RAS) of ZAMBON FARMA, OOO grew over 2019 1.78 times to 126.01 million RUB from 70.66 million RUB over 2018, the company informed. Revenue increased in the accounting period by 0.74% to 3.75 billion RUB from 3.73 billion RUB over 2018; cost of goods sold decreased by 3.01% to 3.26 billion RUB from 3.36 billion RUB; sales profit went up 2.42 times to 220.98 million RUB from 91.17 million RUB. 2018
Net profit (RAS) of ZAMBON FARMA, OOO grew over 2018 4.46 times to 70.66 million RUB from 15.83 million RUB over 2017, the company informed. Revenue increased in the accounting period by 7.99% to 3.73 billion RUB from 3.45 billion RUB over 2017; cost of goods sold grew by 6.53% to 3.36 billion RUB from 3.15 billion RUB; sales profit fell by 2.87% to 91.17 million RUB from 93.87 million RUB. 2017
Net profit (RAS) of ZAMBON FARMA, OOO made up 24.20 million RUB over 2017 compared to net loss of 60.30 million RUB over 2016, the company informed. Revenue increased in the accounting period by 16.03% to 3.45 billion RUB from 2.97 billion RUB over 2016; cost of goods sold grew by 16.08% to 3.15 billion RUB from 2.72 billion RUB; sales profit fell by 11.62% to 93.87 million RUB from 106.21 million RUB. 2016
Net loss (RA) of ZAMBON FARMA, OOO made up 60.30 million RUB over 2016 compared to net profit of 52.96 million RUB over 2015, the company informed. Revenue increased in the accounting period by 8.01% to 2.97 billion RUB from 2.75 billion RUB over 2015; cost of goods sold grew by 9.17% to 2.72 billion RUB from 2.49 billion RUB; sales profit fell by 8.25% to 106.21 million RUB from 115.76 million RUB. 2014
Net profit (RAS) of ZAMBON FARMA, OOO grew over 2014 by 14.67% to 170.79 million RUB from 148.94 million RUB over 2013, the company informed. Revenue increased in the accounting period by 15.45% to 2.59 billion RUB from 2.25 billion RUB over 2013; cost of goods sold grew by 15.17% to 2.19 billion RUB from 1.91 billion RUB; sales profit went up by 14.24% to 239.50 million RUB from 209.64 million RUB. 2013
Net profit (RAS) of ZAMBON FARMA, OOO grew over 2013 3.06 times to 148.94 million RUB from 48.74 million RUB over 2012, the company informed. Revenue increased in the accounting period 2.30 times to 2.25 billion RUB from 975.10 million RUB over 2012; cost of goods sold grew 2.39 times to 1.91 billion RUB from 795.50 million RUB; sales profit went up 2.81 times to 211.55 million RUB from 75.21 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|